DIA Oligonucleotide‑Based Therapeutics Conference

We will be attending the Oligonucleotide‑Based Therapeutics Conference, organized by DIA, to engage with the global oligonucleotide community and exchange insights on the latest developments in oligo-based drug discovery, manufacturing, and clinical advancement.

The conference brings together industry, academia, and regulatory experts to discuss emerging technologies, key challenges, and future directions in therapeutic oligonucleotides.

We look forward to connecting with peers and contributing to conversations shaping the future of oligonucleotide therapeutics.

If you are attending the conference, you are welcome to meet our expert on site.